OREM, Utah--(BUSINESS WIRE)--Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and ...

Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that aim to improve the efficiency and accuracy ...

The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience.

Among companies watching the budget this week are likely to be pathology providers. There’s talk $500m worth of extra funding ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

With over two decades in her profession, Jessica Ann Bradley is celebrated by Marquis Who’s Who and Who’s Who of Professional Women for her dedication, ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

New research shows Alzheimer's blood tests are 90% accurate for white patients but only 73% for Black patients, raising ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...

According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take ...